Chidamide is an oral antitumor agent classified as a histone deacetylase (HDAC) inhibitor. It is primarily indicated for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). It inhibits cancer cell proliferation by regulating gene expression and is a Class 1 innovative drug independently developed in China.
What is Chidamide?
Update: 03 Feb,2026 Source: Haiou Health Views: 105
